Hansen, T. K., Thiel, S., Wouters, P. J.
, Christiansen, J. S. & Van den Berghe, G. . (2003).
Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels.
Journal of Clinical Endocrinology and Metabolism,
88(3), 1082-1088.
Höybye, C., Barkeling, B.
, Espelund, U., Petersson, M. & Thorén, M. (2003).
Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Growth Hormone and IGF Research,
13(6), 322-7.
Jørgensen, J. O. L., Krag, M., Kanaley, J., Møller, J.
, Hansen, T. K., Møller, N., Christiansen, J. S. & Ørskov, H. (2003).
Exercise, hormones, and body temperature. regulation and action of GH during exercise.
Journal of Endocrinological Investigation,
26(9), 838-842.
Jørgensen, J. O. L., Hansen, T. K., Møller, N.
, Christiansen, J. S. & Besser, M. (Ed.) (2003).
Normal physiology of growth hormone in adults. In
Neuroendocrinology, Hypothalamus, and Pituitary (pp. 0-0)
http://www.endotext.com
Knudsen, S. T., Bek, T.
, Poulsen, P. L., Hove, M. N., Rehling, M. & Mogensen, C. E. (2003).
Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study.
Journal of Internal Medicine,
254(2), 147-158.
Knudsen, S. T., Foss, C. H.
, Poulsen, P. L., Bek, T., Ledet, T., Mogensen, C. E. & Rasmussen, L. M. (2003).
E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathy.
American Journal of Physiology: Endocrinology and Metabolism,
284(1), 1-6.
Knudsen, S. T., Foss, C. H., Poulsen, P. L., Bek, T., Ledet, T., Mogensen, C. E. & Rasmussen, L. M. (2003).
E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathy.
A J P: Endocrinology and Metabolism (Online),
284(1), E1-6.
https://doi.org/10.1152/ajpendo.00198.2002
Knudsen, S. T., Foss, C. H.
, Poulsen, P. L., Andersen, N. H., Mogensen, C. E. & Rasmussen, L. M. (2003).
Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications.
European Journal of Endocrinology,
149(1), 39-42.